MR编号 | AT/H/0497/002 |
---|
药品名称 | Bendamustine Accord 25 mg/ml concentrate for solution for infusion |
---|
活性成分 | - Bendamustine hydrochloride 25.0 mg/ml
|
---|
剂型 | Concentrate for solution for infusion |
---|
上市许可持有人 | Accord Healthcare B.V.
Winthontlaan 200
3526KV Utrecht
Niederlande |
---|
参考成员国 - 产品名称 | Austria (AT) |
---|
互认成员国 - 产品名称 | - Slovenia (SI)
- Latvia (LV)
- Bulgaria (BG)
- Italy (IT)
- Czechia (CZ)
BENDAMUSTINE ACCORD 25 MG/ML KONCENTRÁT PRO INFUZNÍ ROZTOK - Norway (NO)
Bendamustine Accord - Germany (DE)
Bendamustine Accord 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung - Slovakia (SK)
Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát - Sweden (SE)
- Romania (RO)
Bendamustina Accord 2,5 mg/ml pulbere pentru concentrat pentru solutie perfuzabila - Greece (GR)
BENDAMUSTINE/ACCORD - Cyprus (CY)
Bendamustine Accord 25mg/ml concentrate for solution for Infusion - Portugal (PT)
- Spain (ES)
- Hungary (HU)
Bendamustine Accord 25 mg/ml koncentrátum oldatos infúzióhoz - France (FR)
- Estonia (EE)
Bendamustine Accord - Ireland (IE)
- Lithuania (LT)
- - Iceland (IS)
Bendamustine Accord 2,5 mg/ml Stofn fyrir innrennslisþykkni, lausn - Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- Poland (PL)
Bendamustine Accord - Belgium (BE)
- Finland (FI)
- Denmark (DK)
|
---|
许可日期 | 2022/01/26 |
---|
最近更新日期 | 2024/12/30 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Line Extension
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|